Related references
Note: Only part of the references are listed.Topical Low Dose Preservative-Free Hydrocortisone Reduces Signs and Symptoms in Patients with Chronic Dry Eye: A Randomized Clinical Trial
Martin Kallab et al.
ADVANCES IN THERAPY (2020)
Safety and Efficacy of Cortisol Phosphate in Hyaluronic Acid Vehicle in the Treatment of Dry Eye in Sjogren Syndrome
Maurizio Rolando et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2017)
TFOS DEWS II pathophysiology report
Anthony J. Bron et al.
OCULAR SURFACE (2017)
TFOS DEWS II Diagnostic Methodology report
James S. Wolffsohn et al.
OCULAR SURFACE (2017)
TFOS DEWS II Management and Therapy Report
Lyndon Jones et al.
OCULAR SURFACE (2017)
TFOS DEWS II Definition and Classification Report
Jennifer P. Craig et al.
OCULAR SURFACE (2017)
Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure
John D. Sheppard et al.
ADVANCES IN THERAPY (2016)
Topical Fluorometholone Treatment for Ocular Dryness in Patients With Sjogren Syndrome A Randomized Clinical Trial in China
Tong Lin et al.
MEDICINE (2015)
Clinical Guidelines for Management of Dry Eye Associated with Sjogren Disease
Gary N. Foulks et al.
OCULAR SURFACE (2015)
Safety and efficacy of 0.1% clobetasone butyrate eyedrops in the treatment of dry eye in Sjogren syndrome
Pasquale Aragona et al.
EUROPEAN JOURNAL OF OPHTHALMOLOGY (2013)
Steroid-Induced latrogenic Glaucoma
M. Reza Razeghinejad et al.
OPHTHALMIC RESEARCH (2012)
The complexity of Sjogren's syndrome: Novel aspects on pathogenesis
Roland Jonsson et al.
IMMUNOLOGY LETTERS (2011)
Primary Sjogren's Syndrome: health experiences and predictors of health quality among patients in the United States
Barbara Segal et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2009)
A Link between Tear Instability and Hyperosmolarity in Dry Eye
Haixia Liu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Management of ocular surface inflammation in Sjogren syndrome
Joon Young Hyon et al.
CORNEA (2007)
Antiinflammatory therapy for dry eye
SC Pflugfelder
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
SC Pflugfelder et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
Grading of corneal and conjunctival staining in the context of other dry eye tests
AJ Bron et al.
CORNEA (2003)
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group
C Vitali et al.
ANNALS OF THE RHEUMATIC DISEASES (2002)
Locally administered ocular corticosteroids - Benefits and risks
CNJ McGhee et al.
DRUG SAFETY (2002)
Reliability and validity of the ocular surface disease index
RM Schiffman et al.
ARCHIVES OF OPHTHALMOLOGY (2000)